Punjab Chemicals & Crop Protection Ltd
Incorporated in 1975, Punjab Chemicals
& Crop Protection Ltd is in the business
of Performance Chemicals[1]
- Market Cap ₹ 1,552 Cr.
- Current Price ₹ 1,267
- High / Low ₹ 1,495 / 662
- Stock P/E 37.0
- Book Value ₹ 297
- Dividend Yield 0.24 %
- ROCE 15.3 %
- ROE 12.1 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 10.4% over past five years.
- Debtor days have increased from 74.8 to 95.4 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
514 | 564 | 537 | 525 | 493 | 643 | 550 | 678 | 933 | 1,006 | 934 | 901 | |
473 | 517 | 497 | 509 | 450 | 576 | 507 | 583 | 793 | 883 | 821 | 801 | |
Operating Profit | 41 | 47 | 41 | 16 | 44 | 67 | 42 | 96 | 140 | 123 | 113 | 99 |
OPM % | 8% | 8% | 8% | 3% | 9% | 10% | 8% | 14% | 15% | 12% | 12% | 11% |
15 | 21 | 40 | 12 | 12 | -2 | 13 | 2 | 1 | 3 | 3 | -3 | |
Interest | 35 | 35 | 50 | 31 | 18 | 17 | 18 | 13 | 12 | 18 | 21 | 18 |
Depreciation | 16 | 19 | 17 | 16 | 14 | 19 | 15 | 15 | 17 | 19 | 22 | 25 |
Profit before tax | 4 | 14 | 14 | -19 | 24 | 29 | 22 | 69 | 112 | 89 | 73 | 54 |
Tax % | 0% | 4% | 4% | 4% | 29% | 42% | 51% | 29% | 25% | 31% | 27% | 27% |
1 | 14 | 13 | -20 | 17 | 17 | 11 | 49 | 83 | 61 | 54 | 39 | |
EPS in Rs | 0.78 | 11.58 | 10.83 | -16.25 | 14.01 | 13.70 | 8.77 | 40.03 | 68.06 | 49.83 | 43.70 | 31.75 |
Dividend Payout % | 0% | 0% | 0% | 0% | 11% | 11% | 17% | 5% | 4% | 6% | 7% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 10% |
3 Years: | -1% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 21% |
5 Years: | 42% |
3 Years: | -21% |
TTM: | -21% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 22% |
3 Years: | 2% |
1 Year: | -12% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 24% |
3 Years: | 17% |
Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Reserves | -46 | -47 | 49 | 46 | 62 | 79 | 85 | 132 | 213 | 268 | 318 | 352 |
365 | 321 | 191 | 151 | 117 | 91 | 99 | 88 | 93 | 94 | 123 | 168 | |
164 | 196 | 205 | 229 | 165 | 189 | 197 | 219 | 238 | 241 | 187 | 268 | |
Total Liabilities | 496 | 482 | 457 | 439 | 356 | 371 | 394 | 451 | 557 | 616 | 640 | 801 |
242 | 232 | 235 | 224 | 177 | 180 | 168 | 189 | 212 | 222 | 236 | 254 | |
CWIP | 3 | 7 | 4 | 6 | 4 | 7 | 15 | 16 | 7 | 20 | 12 | 13 |
Investments | 4 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 8 | 4 |
247 | 243 | 219 | 207 | 174 | 184 | 210 | 245 | 337 | 372 | 384 | 529 | |
Total Assets | 496 | 482 | 457 | 439 | 356 | 371 | 394 | 451 | 557 | 616 | 640 | 801 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
38 | 57 | 105 | 62 | 61 | 68 | 34 | 43 | 34 | 58 | 30 | 25 | |
-1 | -0 | 28 | -5 | -18 | -20 | -15 | -9 | -27 | -38 | -36 | -30 | |
-20 | -72 | -141 | -61 | -43 | -4 | -19 | -24 | -11 | -20 | 4 | 12 | |
Net Cash Flow | 17 | -14 | -8 | -4 | 1 | 45 | 1 | 10 | -3 | 0 | -2 | 7 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51 | 48 | 52 | 44 | 31 | 36 | 32 | 45 | 44 | 52 | 77 | 95 |
Inventory Days | 108 | 95 | 78 | 85 | 83 | 75 | 97 | 91 | 99 | 97 | 85 | 151 |
Days Payable | 94 | 78 | 76 | 148 | 133 | 103 | 100 | 102 | 85 | 80 | 75 | 136 |
Cash Conversion Cycle | 64 | 64 | 54 | -19 | -19 | 7 | 28 | 34 | 58 | 69 | 86 | 110 |
Working Capital Days | 10 | -24 | -3 | -48 | -6 | 2 | 8 | 13 | 38 | 49 | 76 | 104 |
ROCE % | 13% | 13% | 14% | 5% | 20% | 29% | 17% | 38% | 45% | 31% | 22% | 15% |
Documents
Announcements
- Closure of Trading Window 1d
-
Communication To Shareholders - Deduction Of Tax At Source On Dividend
19 Jun - Dividend of INR 3/share announced; detailed TDS tax deduction guidelines for shareholders provided.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 May - Annual Secretarial Compliance Report for FY 2024-25 confirming full SEBI compliance.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
7 May - Transcript of Earnings Call Q4 & FY25 held on May 2, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 May - Scheduled investor meeting on May 9, 2025, with SVAN Investment; no UPSI to be discussed.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT REC
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
Business Overview:[1]
PCCPL operates in Agrochemicals, Pharmaceuticals, and Industrial Chemicals, offering Contract Research and Manufacturing Services (CRAMS) with a focus on innovation.